Cargando…
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
Age is one of the most important risk factors for the development of breast cancer. Nearly a third of all breast cancer cases occur in older women (aged ≥70 years), with most cases being oestrogen receptor-positive (ER+). Such tumours are often indolent and unlikely to be the ultimate cause of death...
Autores principales: | Carleton, Neil, Nasrazadani, Azadeh, Gade, Kristine, Beriwal, Sushil, Barry, Parul N, Brufsky, Adam M, Bhargava, Rohit, Berg, Wendie A, Zuley, Margarita L, van Londen, GJ, Marroquin, Oscar C, Thull, Darcy L, Mai, Phuong L, Diego, Emilia J, Lotze, Michael T, Oesterreich, Steffi, McAuliffe, Priscilla F, Lee, Adrian V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765742/ https://www.ncbi.nlm.nih.gov/pubmed/35047868 http://dx.doi.org/10.1016/s2666-7568(21)00280-4 |
Ejemplares similares
-
Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection
por: Brufsky, Adam, et al.
Publicado: (2020) -
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021) -
Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018) -
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer
por: Carleton, Neil, et al.
Publicado: (2021) -
Artificial intelligence-directed prognostication of breast cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2019)